Ikarian Capital »

Catalyst Pharmaceutical Partners shares owned by Ikarian Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.5M 506k 16.81
2023-09-30 $5.9M 506k 11.69

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Geode Capital Management
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Charles Schwab Investment Management
Goldman Sachs Group
LSV Asset Management
Bank of New York Mellon

View all funds holding Catalyst Pharmaceutical Partners